Communications publiées lors de congrès ou colloques nationaux et internationaux (6)
Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (1)
1.
Haccuria, A., Van Muylem, A., Malinovschi, A., Rasschaert, J., Virreira Bermudez, M., Bruffaerts, N., Hendrickx, M., & Michils, A. (2021). Increased expression of IL-33 is found in the lower airways of patients with seasonal allergic rhinitis and is not related to natural allergen exposure. Clinical and experimental allergy, 00, 1-4. doi:10.1111/cea.13819 Participations à des congrès et colloques internationaux (40)
1.
Haccuria, A., Virreira Bermudez, M., Rasschaert, J., Van Muylem, A., & Michils, A. (2017). IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: A marker of TH2 activation? Paper session presented at Annual Congress of the European Respiratory Society (Sept 3-7, 2017: Milan).2.
Haccuria, A., Virreira Bermudez, M., Rasschaert, J., Van Muylem, A., & Michils, A. (2017). IL-33 in induced sputum of patients with allergic rhinitis. Paper session presented at Annual meeting of the European Academy of Asthma and clinical Immunology (June 7-10, 2017: Helsinki).3.
Haccuria, A., Virreira Bermudez, M., Rasschaert, J., Van Muylem, A., & Michils, A. (2016). Induced sputum levels of soluble receptor ST-2 in adult patients suffering from adult asthma or allergic rhinitis. Paper session presented at Annual Congress of the European Respiratory Society (Sept 6-10, 2016: London).4.
Haccuria, A., Virreira Bermudez, M., Rasschaert, J., Van Muylem, A., & Michils, A. (2016). Induced sputum levels of IL-33 and its soluble receptors sST2 in patients with asthma and allergic rhinitis. Paper session presented at GlaxoSmithKline Awards in Pulmonology & Société Belge de Pneumologie (May 10, 2016: Brussels).